Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors
Feldman, D. R., Hu, J., Dorff, T. B., Lim, K., Patil, S., Woo, K. M., Carousso, M., Hughes, A., Sheinfeld, J., Bains, M., Daneshmand, S., Ketchens, C., Bajorin, D. F., Bosl, G. J., Quinn, D. I., MotzeLanguage:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2016.66.7899
Date:
May, 2016
File:
PDF, 636 KB
english, 2016